Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Tackling Multicomplexity in Aging Patients with RA

Ruth Jessen Hickman, MD  |  November 22, 2021

Frailty & Sarcopenia Screening

Dr. Bühring also recommended other tools that can be helpful for assessing frailty and sarcopenia. Sarcopenia is much more common in people with rheumatoid arthritis than in people in the general population. And, like multimorbidity, sarcopenia and consequent poor muscle function negatively impact daily functioning as measured by the Health Assessment Questionnaire (HAQ).11

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Practitioners can choose among several approaches to screen for sarcopenia, including the SARC-F questionnaire and the Short Physical Performance Battery.12,13 The recent European Consensus guidelines on sarcopenia provide even more detail about the steps needed to make a formal diagnosis.14

A related but somewhat different parameter, frailty, also negatively impacts daily functioning and HAQ scores.15 The Fried Index is a validated measure that is easy to perform in a clinical setting, as is the Simple FRAIL Questionnaire Tool (Fatigue, Resistance, Aerobic, Illnesses, Loss of Weight).16,17 Because one component of frailty is muscle weakness, assessing for frailty somewhat captures sarcopenia status as well.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Bühring emphasized that regular and systematic use is much more important than the specific tools employed. “Pick a tool that you are comfortable with and go with it,” he said. “The key is that you know what your tools are, and you know them well enough that you don’t have to look up how to do them on the spot.”

Treatment & Interdisciplinary Collaboration

Both Dr. Bühring and Dr. Makris emphasized the need for interdisciplinary collaboration when dealing with these complex patients. When a rheumatologist identifies a potential issue, such as impaired cognition, it doesn’t mean they alone are responsible for formal diagnosis and treatment. Rheumatologists should have a network of people they can ask for consultations and refer patients to, ideally others with experience working with older patients with rheumatic disease.

Depending on the context, this may mean other doctors (e.g., rehabilitation specialists, geriatricians, orthopedists, psychiatrists) or other professionals, such as physical therapists, occupational therapists, clinical psychologists, social workers or others.18 “It’s always worth picking up the phone to introduce yourself and also to [learn about] their approach to patient care,” said Dr. Makris.

Dr. Makris argued that for many older adults with complex conditions, nonpharmacological modalities can play a key role in augmenting treatment. She explained that multiple non-pharmacological interventions now have enough evidence behind them that rheumatologists can use them with their patients, although no single approach works for everyone.

“I typically focus on these movement therapies [such as walking programs, tai chi, yoga, aquatic therapy],” Dr. Makris said. “I think that all of our older adult patients could benefit from increasing physical activity, and that could improve both the pain and the mental health comorbidities.” Other approaches, like mindfulness techniques or many others, may also be appropriate.18

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:ACR ConvergenceConditionsMeeting ReportsRheumatoid Arthritis Tagged with:ACR Convergence 2021ACR Convergence 2021 – RAelderlymulticomplexityRheumatoid Arthritis (RA)

Related Articles

    As Population Ages, Rheumatologists Prepare to Treat Elderly Patients with More Comorbidities

    November 1, 2012

    Cardiovascular disease, diabetes are among the conditions that add another layer of complexity in treating older rheumatology patients

    Tips for Interdisciplinary Pain Management in Older Patients

    April 15, 2019

    CHICAGO—Rheumatology healthcare providers should embrace collaborative approaches to manage chronic musculoskeletal pain in older adult patients, including models of care that involve multiple providers, patients and their caregivers. That was the message delivered by two speakers in the Interdisciplinary Management of Chronic Musculo­skeletal Pain in Older Adults session at the 2018 ACR/ARHP Annual Meeting. “As…

    ACR Increases Its Role in Educating Rheumatologists About Treating Geriatric Patients

    November 1, 2012

    Sessions on aging and rheumatic disease, arthritis and the older worker, and back pain in the elderly included at the annual meeting of the American College of Rheumatology and Association of Rheumatology Healthcare Professionals (ACR/ARHP)

    How to Optimize Treatment for Aging Patients with Rheumatic Conditions

    August 30, 2023

    As patients with rheumatic musculoskeletal disease age, the number of medications they take may increase (i.e., polypharmacy), which can result in unwanted side effects and serious adverse effects. Lee et al. offer considerations and insights into caring for aging patients in a polypharmacy situation to better meet their health and lifestyle needs.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences